Baidu
map

神经科

订阅

MedSci主页 / 所有栏目 / 神经科

Neurology：卒中相关性血脑屏障渗漏一例

2021-12-15 ANDs 网络

缺血性卒中
关注

FLAIR序列上与卒中相关的蛛网膜下腔和眼部钆渗漏可能代表了血脑/眼屏障破坏。早期的一份报告描述了卒中后>1个月进行的MRI可见到PVS钆渗漏。类淋巴系统（glymphatic）（在脑脊液-间质液交换

74岁，男性，右侧分水岭梗死。

入院时钆增强MRI显示右侧分水岭梗死（下图）。肾功能正常。4小时后MRI显示同侧血管周围间隙（PVS）和蛛网膜下腔FLAIR高信号，可能与卒中相关性延迟性钆渗漏有关（图）。10天后的MRI显示蛛网膜下腔/血管周围异常完全消失（图）。

下图，入院MRI（钆注射 MRA）显示右侧梗死（A，DWI）和血管周围间隙（PVS）（B，T1加权成像；C，FLAIR）。（D–F）四小时后，MRI显示同侧蛛网膜下腔（箭头）和深部及皮质下PVS（箭头）FLAIR高信号，为钆渗漏所致。（G–I）10天后观察到蛛网膜下腔/血管周围FLAIR异常信号完全消失：

FLAIR序列上与卒中相关的蛛网膜下腔和眼部钆渗漏可能代表了血脑/眼屏障破坏。早期的一份报告描述了卒中后>1个月进行的MRI可见到PVS钆渗漏。类淋巴系统（glymphatic）（在脑脊液-间质液交换中发挥作用）可能参与了蛛网膜下腔和PVS中观察到的卒中相关性血脑屏障渗漏。

文献出处：

Perivascular and Subarachnoid Fluid-Attenuated Inversion Recovery Hyperintensities Related to Delayed Gadolinium Leakage After Stroke. Neurology. 2021 Nov 23;97(21):1000-1001. doi: 10.1212/WNL.0000000000012854. Epub 2021 Sep 23.

 

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1838019, encodeId=f3d1183801946, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Jun 16 15:00:18 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001650, encodeId=c705200165036, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Dec 29 15:00:18 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081716, encodeId=65bb1081e16df, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b261695631, createdName=小明4083, createdTime=Sun Dec 19 09:04:07 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262382, encodeId=bc761262382b3, content=<a href='/topic/show?id=ff3c89946de' target=_blank style='color:#2F92EE;'>#血脑屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89946, encryptionId=ff3c89946de, topicName=血脑屏障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Sun Dec 19 02:00:18 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081584, encodeId=61e6108158451, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09985652468, createdName=ms6000000145764456, createdTime=Sat Dec 18 19:02:56 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2022-06-16 shenxlcyp

    #相关性#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1838019, encodeId=f3d1183801946, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Jun 16 15:00:18 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001650, encodeId=c705200165036, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Dec 29 15:00:18 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081716, encodeId=65bb1081e16df, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b261695631, createdName=小明4083, createdTime=Sun Dec 19 09:04:07 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262382, encodeId=bc761262382b3, content=<a href='/topic/show?id=ff3c89946de' target=_blank style='color:#2F92EE;'>#血脑屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89946, encryptionId=ff3c89946de, topicName=血脑屏障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Sun Dec 19 02:00:18 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081584, encodeId=61e6108158451, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09985652468, createdName=ms6000000145764456, createdTime=Sat Dec 18 19:02:56 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-29 yinhl1978

    #Neurol#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1838019, encodeId=f3d1183801946, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Jun 16 15:00:18 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001650, encodeId=c705200165036, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Dec 29 15:00:18 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081716, encodeId=65bb1081e16df, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b261695631, createdName=小明4083, createdTime=Sun Dec 19 09:04:07 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262382, encodeId=bc761262382b3, content=<a href='/topic/show?id=ff3c89946de' target=_blank style='color:#2F92EE;'>#血脑屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89946, encryptionId=ff3c89946de, topicName=血脑屏障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Sun Dec 19 02:00:18 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081584, encodeId=61e6108158451, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09985652468, createdName=ms6000000145764456, createdTime=Sat Dec 18 19:02:56 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-19 小明4083

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1838019, encodeId=f3d1183801946, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Jun 16 15:00:18 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001650, encodeId=c705200165036, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Dec 29 15:00:18 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081716, encodeId=65bb1081e16df, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b261695631, createdName=小明4083, createdTime=Sun Dec 19 09:04:07 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262382, encodeId=bc761262382b3, content=<a href='/topic/show?id=ff3c89946de' target=_blank style='color:#2F92EE;'>#血脑屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89946, encryptionId=ff3c89946de, topicName=血脑屏障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Sun Dec 19 02:00:18 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081584, encodeId=61e6108158451, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09985652468, createdName=ms6000000145764456, createdTime=Sat Dec 18 19:02:56 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-19 zhangying8788

    #血脑屏障#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1838019, encodeId=f3d1183801946, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Thu Jun 16 15:00:18 CST 2022, time=2022-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2001650, encodeId=c705200165036, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Wed Dec 29 15:00:18 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081716, encodeId=65bb1081e16df, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b261695631, createdName=小明4083, createdTime=Sun Dec 19 09:04:07 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1262382, encodeId=bc761262382b3, content=<a href='/topic/show?id=ff3c89946de' target=_blank style='color:#2F92EE;'>#血脑屏障#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89946, encryptionId=ff3c89946de, topicName=血脑屏障)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=68b666, createdName=zhangying8788, createdTime=Sun Dec 19 02:00:18 CST 2021, time=2021-12-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1081584, encodeId=61e6108158451, content=学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=09985652468, createdName=ms6000000145764456, createdTime=Sat Dec 18 19:02:56 CST 2021, time=2021-12-18, status=1, ipAttribution=)]
    2021-12-18 ms6000000145764456

    学习

    0

相关资讯

JAMA子刊：20年来，缺血性和出血性中风的严重程度和结果变化

在过去的20年里，缺血性卒中患者的功能预后都有所改善

JAHA：血浆三甲基赖氨酸水平与缺血性卒中患者预后的关系

血浆中三甲基赖氨酸水平升高与缺血性卒中/短暂性脑缺血发作患者的心血管死亡相关。介导分析表明，三甲基赖氨酸通过炎症和肾功能促进心血管死亡，这表明它们之间可能存在病理学机制的联系。

Stroke：TMAO水平与缺血性卒中复发相关（CNSR-III研究）

王拥军教授团队利用第三次中国国家卒中登记研究（Third China National Stroke Registry, CNSR-III）队列，探讨了不同病因亚型下血浆氧化三甲胺与缺血性卒中复发之间

Neurology：脑血管侧支完整性越好，卒中儿童卒中负担更小、早期梗死增长更慢

在接受血栓摘除术的缺血性卒中儿童中，良好的侧支与改善放射学结果有关，但与更好的临床结果无关。

Neurology：与突发缺血性卒中相关的代谢组学特征

近日，研究人员调查了护士健康研究(NHS)的女性参与者的代谢物特征与偶发缺血性卒中之间的关系，与卒中相关的代谢物包括2种氨基酸 、1种羧酸、1种蔗糖，包含这些代谢物的复合SMS可准确预测缺血性卒中风险

NEJM：海军军医大学刘建民团队揭示4.5小时以内的急性前循环大血管闭塞性缺血性卒中患者可直接取栓

brainnews神内神外，关注神内神外相关前沿资讯

Baidu
map
Baidu
map
Baidu
map